Global Dry Eye Medication Market Growth 2023-2029

February 2023 | 108 pages | ID: G66FD39B9425EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

LPI (LP Information)' newest research report, the “Dry Eye Medication Industry Forecast” looks at past sales and reviews total world Dry Eye Medication sales in 2022, providing a comprehensive analysis by region and market sector of projected Dry Eye Medication sales for 2023 through 2029. With Dry Eye Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Eye Medication industry.

This Insight Report provides a comprehensive analysis of the global Dry Eye Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Eye Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dry Eye Medication market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Eye Medication and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Eye Medication.

The global Dry Eye Medication market size is projected to grow from US$ 8392.4 million in 2022 to US$ 10700 million in 2029; it is expected to grow at a CAGR of 10700 from 2023 to 2029.

Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.

North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.

In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.

This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Medication market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Anti-inflammatory Drugs
• Artificial Tears
• Punctal Plugs
• Secretagogues
• Others

Segmentation by application

• Hospital
• Pharmacies
• Eye Health Clinics
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• EyeGate Pharmaceuticals
• Allergan
• Novartis
• Merck
• Santen Pharmaceutical
• Shire
• Alcon
• Bausch Health Companies
• Johnson and Johnson
• VISUfarma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Dry Eye Medication market?

What factors are driving Dry Eye Medication market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Dry Eye Medication market opportunities vary by end market size?

How does Dry Eye Medication break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dry Eye Medication Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Dry Eye Medication by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Dry Eye Medication by Country/Region, 2018, 2022 & 2029
2.2 Dry Eye Medication Segment by Type
  2.2.1 Anti-inflammatory Drugs
  2.2.2 Artificial Tears
  2.2.3 Punctal Plugs
  2.2.4 Secretagogues
  2.2.5 Others
2.3 Dry Eye Medication Sales by Type
  2.3.1 Global Dry Eye Medication Sales Market Share by Type (2018-2023)
  2.3.2 Global Dry Eye Medication Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Dry Eye Medication Sale Price by Type (2018-2023)
2.4 Dry Eye Medication Segment by Application
  2.4.1 Hospital
  2.4.2 Pharmacies
  2.4.3 Eye Health Clinics
  2.4.4 Retail Pharmacies
  2.4.5 Online Pharmacies
2.5 Dry Eye Medication Sales by Application
  2.5.1 Global Dry Eye Medication Sale Market Share by Application (2018-2023)
  2.5.2 Global Dry Eye Medication Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Dry Eye Medication Sale Price by Application (2018-2023)

3 GLOBAL DRY EYE MEDICATION BY COMPANY

3.1 Global Dry Eye Medication Breakdown Data by Company
  3.1.1 Global Dry Eye Medication Annual Sales by Company (2018-2023)
  3.1.2 Global Dry Eye Medication Sales Market Share by Company (2018-2023)
3.2 Global Dry Eye Medication Annual Revenue by Company (2018-2023)
  3.2.1 Global Dry Eye Medication Revenue by Company (2018-2023)
  3.2.2 Global Dry Eye Medication Revenue Market Share by Company (2018-2023)
3.3 Global Dry Eye Medication Sale Price by Company
3.4 Key Manufacturers Dry Eye Medication Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Dry Eye Medication Product Location Distribution
  3.4.2 Players Dry Eye Medication Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DRY EYE MEDICATION BY GEOGRAPHIC REGION

4.1 World Historic Dry Eye Medication Market Size by Geographic Region (2018-2023)
  4.1.1 Global Dry Eye Medication Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Dry Eye Medication Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Dry Eye Medication Market Size by Country/Region (2018-2023)
  4.2.1 Global Dry Eye Medication Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Dry Eye Medication Annual Revenue by Country/Region (2018-2023)
4.3 Americas Dry Eye Medication Sales Growth
4.4 APAC Dry Eye Medication Sales Growth
4.5 Europe Dry Eye Medication Sales Growth
4.6 Middle East & Africa Dry Eye Medication Sales Growth

5 AMERICAS

5.1 Americas Dry Eye Medication Sales by Country
  5.1.1 Americas Dry Eye Medication Sales by Country (2018-2023)
  5.1.2 Americas Dry Eye Medication Revenue by Country (2018-2023)
5.2 Americas Dry Eye Medication Sales by Type
5.3 Americas Dry Eye Medication Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dry Eye Medication Sales by Region
  6.1.1 APAC Dry Eye Medication Sales by Region (2018-2023)
  6.1.2 APAC Dry Eye Medication Revenue by Region (2018-2023)
6.2 APAC Dry Eye Medication Sales by Type
6.3 APAC Dry Eye Medication Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Dry Eye Medication by Country
  7.1.1 Europe Dry Eye Medication Sales by Country (2018-2023)
  7.1.2 Europe Dry Eye Medication Revenue by Country (2018-2023)
7.2 Europe Dry Eye Medication Sales by Type
7.3 Europe Dry Eye Medication Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dry Eye Medication by Country
  8.1.1 Middle East & Africa Dry Eye Medication Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Dry Eye Medication Revenue by Country (2018-2023)
8.2 Middle East & Africa Dry Eye Medication Sales by Type
8.3 Middle East & Africa Dry Eye Medication Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dry Eye Medication
10.3 Manufacturing Process Analysis of Dry Eye Medication
10.4 Industry Chain Structure of Dry Eye Medication

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Dry Eye Medication Distributors
11.3 Dry Eye Medication Customer

12 WORLD FORECAST REVIEW FOR DRY EYE MEDICATION BY GEOGRAPHIC REGION

12.1 Global Dry Eye Medication Market Size Forecast by Region
  12.1.1 Global Dry Eye Medication Forecast by Region (2024-2029)
  12.1.2 Global Dry Eye Medication Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dry Eye Medication Forecast by Type
12.7 Global Dry Eye Medication Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 EyeGate Pharmaceuticals
  13.1.1 EyeGate Pharmaceuticals Company Information
  13.1.2 EyeGate Pharmaceuticals Dry Eye Medication Product Portfolios and Specifications
  13.1.3 EyeGate Pharmaceuticals Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 EyeGate Pharmaceuticals Main Business Overview
  13.1.5 EyeGate Pharmaceuticals Latest Developments
13.2 Allergan
  13.2.1 Allergan Company Information
  13.2.2 Allergan Dry Eye Medication Product Portfolios and Specifications
  13.2.3 Allergan Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Allergan Main Business Overview
  13.2.5 Allergan Latest Developments
13.3 Novartis
  13.3.1 Novartis Company Information
  13.3.2 Novartis Dry Eye Medication Product Portfolios and Specifications
  13.3.3 Novartis Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Novartis Main Business Overview
  13.3.5 Novartis Latest Developments
13.4 Merck
  13.4.1 Merck Company Information
  13.4.2 Merck Dry Eye Medication Product Portfolios and Specifications
  13.4.3 Merck Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Merck Main Business Overview
  13.4.5 Merck Latest Developments
13.5 Santen Pharmaceutical
  13.5.1 Santen Pharmaceutical Company Information
  13.5.2 Santen Pharmaceutical Dry Eye Medication Product Portfolios and Specifications
  13.5.3 Santen Pharmaceutical Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Santen Pharmaceutical Main Business Overview
  13.5.5 Santen Pharmaceutical Latest Developments
13.6 Shire
  13.6.1 Shire Company Information
  13.6.2 Shire Dry Eye Medication Product Portfolios and Specifications
  13.6.3 Shire Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Shire Main Business Overview
  13.6.5 Shire Latest Developments
13.7 Alcon
  13.7.1 Alcon Company Information
  13.7.2 Alcon Dry Eye Medication Product Portfolios and Specifications
  13.7.3 Alcon Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Alcon Main Business Overview
  13.7.5 Alcon Latest Developments
13.8 Bausch Health Companies
  13.8.1 Bausch Health Companies Company Information
  13.8.2 Bausch Health Companies Dry Eye Medication Product Portfolios and Specifications
  13.8.3 Bausch Health Companies Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Bausch Health Companies Main Business Overview
  13.8.5 Bausch Health Companies Latest Developments
13.9 Johnson and Johnson
  13.9.1 Johnson and Johnson Company Information
  13.9.2 Johnson and Johnson Dry Eye Medication Product Portfolios and Specifications
  13.9.3 Johnson and Johnson Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Johnson and Johnson Main Business Overview
  13.9.5 Johnson and Johnson Latest Developments
13.10 VISUfarma
  13.10.1 VISUfarma Company Information
  13.10.2 VISUfarma Dry Eye Medication Product Portfolios and Specifications
  13.10.3 VISUfarma Dry Eye Medication Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 VISUfarma Main Business Overview
  13.10.5 VISUfarma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Dry Eye Medication Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Dry Eye Medication Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Anti-inflammatory Drugs
Table 4. Major Players of Artificial Tears
Table 5. Major Players of Punctal Plugs
Table 6. Major Players of Secretagogues
Table 7. Major Players of Others
Table 8. Global Dry Eye Medication Sales by Type (2018-2023) & (K Units)
Table 9. Global Dry Eye Medication Sales Market Share by Type (2018-2023)
Table 10. Global Dry Eye Medication Revenue by Type (2018-2023) & ($ million)
Table 11. Global Dry Eye Medication Revenue Market Share by Type (2018-2023)
Table 12. Global Dry Eye Medication Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Dry Eye Medication Sales by Application (2018-2023) & (K Units)
Table 14. Global Dry Eye Medication Sales Market Share by Application (2018-2023)
Table 15. Global Dry Eye Medication Revenue by Application (2018-2023)
Table 16. Global Dry Eye Medication Revenue Market Share by Application (2018-2023)
Table 17. Global Dry Eye Medication Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Dry Eye Medication Sales by Company (2018-2023) & (K Units)
Table 19. Global Dry Eye Medication Sales Market Share by Company (2018-2023)
Table 20. Global Dry Eye Medication Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Dry Eye Medication Revenue Market Share by Company (2018-2023)
Table 22. Global Dry Eye Medication Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Dry Eye Medication Producing Area Distribution and Sales Area
Table 24. Players Dry Eye Medication Products Offered
Table 25. Dry Eye Medication Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Dry Eye Medication Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Dry Eye Medication Sales Market Share Geographic Region (2018-2023)
Table 30. Global Dry Eye Medication Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Dry Eye Medication Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Dry Eye Medication Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Dry Eye Medication Sales Market Share by Country/Region (2018-2023)
Table 34. Global Dry Eye Medication Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Dry Eye Medication Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Dry Eye Medication Sales by Country (2018-2023) & (K Units)
Table 37. Americas Dry Eye Medication Sales Market Share by Country (2018-2023)
Table 38. Americas Dry Eye Medication Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Dry Eye Medication Revenue Market Share by Country (2018-2023)
Table 40. Americas Dry Eye Medication Sales by Type (2018-2023) & (K Units)
Table 41. Americas Dry Eye Medication Sales by Application (2018-2023) & (K Units)
Table 42. APAC Dry Eye Medication Sales by Region (2018-2023) & (K Units)
Table 43. APAC Dry Eye Medication Sales Market Share by Region (2018-2023)
Table 44. APAC Dry Eye Medication Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Dry Eye Medication Revenue Market Share by Region (2018-2023)
Table 46. APAC Dry Eye Medication Sales by Type (2018-2023) & (K Units)
Table 47. APAC Dry Eye Medication Sales by Application (2018-2023) & (K Units)
Table 48. Europe Dry Eye Medication Sales by Country (2018-2023) & (K Units)
Table 49. Europe Dry Eye Medication Sales Market Share by Country (2018-2023)
Table 50. Europe Dry Eye Medication Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Dry Eye Medication Revenue Market Share by Country (2018-2023)
Table 52. Europe Dry Eye Medication Sales by Type (2018-2023) & (K Units)
Table 53. Europe Dry Eye Medication Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Dry Eye Medication Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Dry Eye Medication Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Dry Eye Medication Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Dry Eye Medication Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Dry Eye Medication Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Dry Eye Medication Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Dry Eye Medication
Table 61. Key Market Challenges & Risks of Dry Eye Medication
Table 62. Key Industry Trends of Dry Eye Medication
Table 63. Dry Eye Medication Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Dry Eye Medication Distributors List
Table 66. Dry Eye Medication Customer List
Table 67. Global Dry Eye Medication Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Dry Eye Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Dry Eye Medication Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Dry Eye Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Dry Eye Medication Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Dry Eye Medication Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Dry Eye Medication Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Dry Eye Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Dry Eye Medication Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Dry Eye Medication Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Dry Eye Medication Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Dry Eye Medication Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Dry Eye Medication Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Dry Eye Medication Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. EyeGate Pharmaceuticals Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 82. EyeGate Pharmaceuticals Dry Eye Medication Product Portfolios and Specifications
Table 83. EyeGate Pharmaceuticals Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. EyeGate Pharmaceuticals Main Business
Table 85. EyeGate Pharmaceuticals Latest Developments
Table 86. Allergan Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 87. Allergan Dry Eye Medication Product Portfolios and Specifications
Table 88. Allergan Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Allergan Main Business
Table 90. Allergan Latest Developments
Table 91. Novartis Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Dry Eye Medication Product Portfolios and Specifications
Table 93. Novartis Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Merck Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 97. Merck Dry Eye Medication Product Portfolios and Specifications
Table 98. Merck Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Merck Main Business
Table 100. Merck Latest Developments
Table 101. Santen Pharmaceutical Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 102. Santen Pharmaceutical Dry Eye Medication Product Portfolios and Specifications
Table 103. Santen Pharmaceutical Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Santen Pharmaceutical Main Business
Table 105. Santen Pharmaceutical Latest Developments
Table 106. Shire Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 107. Shire Dry Eye Medication Product Portfolios and Specifications
Table 108. Shire Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Shire Main Business
Table 110. Shire Latest Developments
Table 111. Alcon Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 112. Alcon Dry Eye Medication Product Portfolios and Specifications
Table 113. Alcon Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Alcon Main Business
Table 115. Alcon Latest Developments
Table 116. Bausch Health Companies Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 117. Bausch Health Companies Dry Eye Medication Product Portfolios and Specifications
Table 118. Bausch Health Companies Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Bausch Health Companies Main Business
Table 120. Bausch Health Companies Latest Developments
Table 121. Johnson and Johnson Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 122. Johnson and Johnson Dry Eye Medication Product Portfolios and Specifications
Table 123. Johnson and Johnson Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Johnson and Johnson Main Business
Table 125. Johnson and Johnson Latest Developments
Table 126. VISUfarma Basic Information, Dry Eye Medication Manufacturing Base, Sales Area and Its Competitors
Table 127. VISUfarma Dry Eye Medication Product Portfolios and Specifications
Table 128. VISUfarma Dry Eye Medication Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. VISUfarma Main Business
Table 130. VISUfarma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Dry Eye Medication
Figure 2. Dry Eye Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Eye Medication Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Dry Eye Medication Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Dry Eye Medication Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Anti-inflammatory Drugs
Figure 10. Product Picture of Artificial Tears
Figure 11. Product Picture of Punctal Plugs
Figure 12. Product Picture of Secretagogues
Figure 13. Product Picture of Others
Figure 14. Global Dry Eye Medication Sales Market Share by Type in 2022
Figure 15. Global Dry Eye Medication Revenue Market Share by Type (2018-2023)
Figure 16. Dry Eye Medication Consumed in Hospital
Figure 17. Global Dry Eye Medication Market: Hospital (2018-2023) & (K Units)
Figure 18. Dry Eye Medication Consumed in Pharmacies
Figure 19. Global Dry Eye Medication Market: Pharmacies (2018-2023) & (K Units)
Figure 20. Dry Eye Medication Consumed in Eye Health Clinics
Figure 21. Global Dry Eye Medication Market: Eye Health Clinics (2018-2023) & (K Units)
Figure 22. Dry Eye Medication Consumed in Retail Pharmacies
Figure 23. Global Dry Eye Medication Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 24. Dry Eye Medication Consumed in Online Pharmacies
Figure 25. Global Dry Eye Medication Market: Online Pharmacies (2018-2023) & (K Units)
Figure 26. Global Dry Eye Medication Sales Market Share by Application (2022)
Figure 27. Global Dry Eye Medication Revenue Market Share by Application in 2022
Figure 28. Dry Eye Medication Sales Market by Company in 2022 (K Units)
Figure 29. Global Dry Eye Medication Sales Market Share by Company in 2022
Figure 30. Dry Eye Medication Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Dry Eye Medication Revenue Market Share by Company in 2022
Figure 32. Global Dry Eye Medication Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Dry Eye Medication Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Dry Eye Medication Sales 2018-2023 (K Units)
Figure 35. Americas Dry Eye Medication Revenue 2018-2023 ($ Millions)
Figure 36. APAC Dry Eye Medication Sales 2018-2023 (K Units)
Figure 37. APAC Dry Eye Medication Revenue 2018-2023 ($ Millions)
Figure 38. Europe Dry Eye Medication Sales 2018-2023 (K Units)
Figure 39. Europe Dry Eye Medication Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Dry Eye Medication Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa Dry Eye Medication Revenue 2018-2023 ($ Millions)
Figure 42. Americas Dry Eye Medication Sales Market Share by Country in 2022
Figure 43. Americas Dry Eye Medication Revenue Market Share by Country in 2022
Figure 44. Americas Dry Eye Medication Sales Market Share by Type (2018-2023)
Figure 45. Americas Dry Eye Medication Sales Market Share by Application (2018-2023)
Figure 46. United States Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Dry Eye Medication Sales Market Share by Region in 2022
Figure 51. APAC Dry Eye Medication Revenue Market Share by Regions in 2022
Figure 52. APAC Dry Eye Medication Sales Market Share by Type (2018-2023)
Figure 53. APAC Dry Eye Medication Sales Market Share by Application (2018-2023)
Figure 54. China Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Dry Eye Medication Sales Market Share by Country in 2022
Figure 62. Europe Dry Eye Medication Revenue Market Share by Country in 2022
Figure 63. Europe Dry Eye Medication Sales Market Share by Type (2018-2023)
Figure 64. Europe Dry Eye Medication Sales Market Share by Application (2018-2023)
Figure 65. Germany Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Dry Eye Medication Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Dry Eye Medication Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Dry Eye Medication Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Dry Eye Medication Sales Market Share by Application (2018-2023)
Figure 74. Egypt Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Dry Eye Medication Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Dry Eye Medication in 2022
Figure 80. Manufacturing Process Analysis of Dry Eye Medication
Figure 81. Industry Chain Structure of Dry Eye Medication
Figure 82. Channels of Distribution
Figure 83. Global Dry Eye Medication Sales Market Forecast by Region (2024-2029)
Figure 84. Global Dry Eye Medication Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Dry Eye Medication Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Dry Eye Medication Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Dry Eye Medication Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Dry Eye Medication Revenue Market Share Forecast by Application (2024-2029)